A single measurement of biochemical markers of bane turnover has limited utility in the individual person

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 4, 1997, Pages 351-359

  Jensen, J E Beck ^a,b   Kollerup, G ^a   Sorensen H A ^a   Nielsen, S Pors ^a   Sorensen O H ^a  

^a Copenhagen Municipal Hospital ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Biochemical bone markers; Biological variation; Critical difference; Index of individuality; Number of samples; Predictive value

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; HYDROXYPROLINE; OSTEOCALCIN; PYRIDINOLINE;

ARTICLE; BLOOD ANALYSIS; BONE ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MENOPAUSE; NORMAL HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; URINALYSIS; VARIABILITY;

EID: 8544277217     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709099408     Document Type: Article

References (38)

1. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 881-9.
2. Reeve J, Pearson J, Mitchell A, et al. Evolution of spinal bone loss and biochemical markers of bone remodelling after menopause in normal women. Calcif Tissue Int 1995; 57: 105-10.
3. Mole PA, Walkinshaw MH, Robins SP, Paterson CR. Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause? Eur J Clin Invest 1992; 22: 767-71.
4. Kawana K, Kushida K, Takahashi M, et al. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Calcif Tissue Int 1994; 55: 420-5.
5. Harris ST, Gertz BJ, Genant HK, et al. The effect of short term treatment with alendtonate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrin Metab 1993; 70: 1399-406.
6. Garnero P, Weichung JS, Gineyts E, Karp DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrin Metab 1994; 79: 1693-700.
7. Adami S, Passen M, Ortolani S, et al. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone 1995; 17: 383-90.
8. Christiansen C, Riis BJ, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105-7.
9. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 1991; 303: 961-4.
10. Keen RW, Hall GM, Nandra D, et al. Early postmenopausal bone loss and biochemical markers. Bone 1995; 16 Suppl 1: 108S.
11. Hui SL, Slemanda CW, Johnston Jr CC. The contribution of bone loss to postmenopausal osteoporosis. Osteoporosis Int 1990; 11: 30-4.
12. Falch JA, Sandvik L. Perimenopausal appendicular bone loss: A 10-year prospective study. Bone 1990; 11: 425-8.
13. Nordin BEC, Cleghorn DB, Chatterton BE, Morris HA, Need AG. A 5-year longitudinal study of forearm bone mass i 307 postmenopausal women. J Bone Miner Res 1993; 8: 1427-32.
14. Jensen J-E B, Sørensen HA, Kollerup G, Jensen LB, Sørensen OH. Biological variation of biochemical bone markers. Scand J Clin Invest 1994; 54 Suppl 219: 36-39.
15. Blumsohn RA, Hannon RA, Al-Dehaimi AW, Eastell R. Short-term intraindividual variability of markers of bone turnover in healthy adults. J Bone Miner Res 1994; 9 Suppl 1: S153.
16. Vasikaran SD, McCloskey EV, Kahn S, Kanis JA. Intra-individual variation in fasting urinary calcium- and hydroxyproline-creatinine ratios measured in metabolic bone clinic patients as both outpatients and inpatients. Ann Clin Biochem 1994; 31: 272-6.
17. Panteghini M, Pagani F. Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995; 55: 609-16.
18. Kollerup G, Thamsborg G, Bhatia H, Sørensen OH. Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 1992; 52: 657-62.
19. Kivirikko KT, Laitinen O, Prockop DJ. Modification of a specific assay for hydroxyproline in urine. Analyt Biochem 1967; 19: 249-55.
20. Magid E, Petersen PH, Christensen M. A note on the theory of reference changes. Scand J Clin Invest 1992; 52 Suppl 208: 95-101.
21. Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974; 20: 1535-42.
22. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-37.
23. Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 1993; 91: 1138-48.
24. Colwell A, Russell RGG, Eastell R. Factors affecting the assay of urinary 3-hydroxypyridinium crosslinks of collagen as markers of bone resorption. Eur J Clin Invest 1993; 25: 341-9.
25. Nielsen HK, Brixen K, Mosekilde L. Diurnal rhythm and 24-h integrated concentrations of serum osteocalcin in normals: Influence of age, sex, season, and smoking habits. Calcif Tissue Int 1990; 47: 284-90.
26. Bollen A-M, Martin MD, Leroux BG, Eyre DR. Circadian variation in urinary excretion of bone collagen cross-links. J Bone Miner Res 1995; 10: 1885-90.
27. Gowans EMS, Fraser CG. Biological variation in analyte concentrations in urine of apparently healthy men and women. Clin Chem 1987; 33: 847-50.
28. Price CP, Thompson PW. The role of biochemical tests in the screening and monitoring of osteoporosis. Ann Clin Biochem 1995; 32: 244-60.
29. Azria M. The value of biomarkers in detecting alterations in bone metabolism. Calcif Tissue Int 1989; 45: 7-11.
30. Altman DG. Practical Statistics for Medical Research. Chapman & Hall 1991: 307.
31. Blumsohn A, Eastell R. Prediction of bone loss in postmenopausal women. Eur J Clin Invest 1992; 22: 764-66.
32. Hannon RA, Blumsohn A, Colwell A, Peel NFA, Eastell R. Biochemical markers of bone turnover and the prediction of spinal bone loss in older women. J Bone Miner Res 1994; 9 Suppl 1: S399.
33. Johnell O, Mellström D, Gause-Nilsson I, Johansson C, Lindstedt G. Can we improve the prediction of fractures? J Bone Miner Res 1994; 9 Suppl 1: S402.
34. Falch JA. Can biochemical markers tell us anything about rate of bone loss? Scand J Clin Invest 1994; 54 Suppl 219: 40-1.
35. Kleerekoper M, Wilson PS, Simpson P. Within subject variability of biochemical markers of bone remodeling in normal older women. J Bone Miner Res 1994: 9 Suppl 1: S394.
36. Black DM. Why elderly women should be screened and treated to prevent osteoporosis. Amer J Med 1995; 98 Suppl 2A: 67S-75S.
37. Åkesson K, Ljunghall S, Jonsson B, et al. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J Bone Miner Res 1995; 10: 1823-9.
38. Lindsay MB. Screening for osteoporosis. Syllabus - 46th Postgraduate Assembly Endocrine Society 1994: 212-3.